CD140b and CD73 are markers for human induced pluripotent stem cell‐derived erythropoietin‐producing cells

Renal anemia in chronic kidney disease is treated with recombinant human erythropoietin (rhEPO). However, some patients with anemia do not respond well to rhEPO, emphasizing the need for a more biocompatible EPO. Differentiation protocols for hepatic lineages have been modified to enable production...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Shogo, Mizuno, Tomohiro, Takahashi, Kazuo, Nagano, Fumihiko, Yuzawa, Yukio, Nishiyama, Akira, Osafune, Kenji, Hitomi, Hirofumi, Nagamatsu, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050240/
https://www.ncbi.nlm.nih.gov/pubmed/31977161
http://dx.doi.org/10.1002/2211-5463.12800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050240/
https://www.ncbi.nlm.nih.gov/pubmed/31977161
http://dx.doi.org/10.1002/2211-5463.12800

Ejemplares similares